Towards a better understanding of the puzzling “droplets” in the cell cytoplasm Blog Post

A study at IRB Barcelona, located at PCB, sheds light on the dynamics of protein aggregates that behave like “droplets of oil in water” and that are described as membraneless cytoplasmic organelles.These organelles regulate protein activity during cell division.This is the first study at the Institute to address the so-called liquid-like droplets, which are attracting the attention of researchers worldwide.

 

Omega-3 fatty acids stimulate brown adipose tissue metabolism Blog Post

Omega-3 fatty acids are able to stimulate the activation of brown and beige adipose tissues, a discovery that would promote the development of new therapies for obesity and other metabolism diseases, according to a research study published in the journal Nature Communications under the supervision of Professor Francesc Villarroya, from the Department of Biochemistry and Molecular Biomedicine and member of the Institute of Biomedicine of the University of Barcelona (IBUB) –located at PCB– and the Biomedical Research Center Red-Fisiopatología de la Obesidad y Nutrición (CIBEROBN) of the Institute of Health Carlos III.

 

Understanding epigenetic changes: one more step towards precision medicine Blog Post

Researchers at the Centro Nacional de Análisis Genómico (CNAG-CRG), based at the Barcelona Science Park (PCB), participate in a series of articles simultaneously published by scientists from across the International Human Epigenome Consortium (IHEC) in prestigious scientific journals. The collection of publications showcases the achievements and scientific progress made by IHEC in core areas of current epigenetic investigations.

 

Esteve and Boehringer Ingelheim enter into an agreement to help patients with atrial fibrillation Blog Post

Esteve and Boehringer Ingelheim have reached an agreement whereby they enter into a joint promotion to share their commitment to improving the lives of patients with non-valvular atrial fibrillation (NVAF) at risk of suffering a stroke. In June 2012, Esteve has moved its Center for Drug Discovery and Preclinical Development to the Barcelona Science Park (PCB) in an attempt to shorten development time and speed up the arrival to market of innovative new drugs. 

 

Drug repurposing, a new hope for rare diseases Blog Post

Under the theme Drug repurposing for rare diseases. The cure of the 21st centuryB·Debate – an initiative by Biocat and  “la Caixa” Foundation– will be holding, in association with the Barcelona Science Park (PCB) and Hospital Sant Joan de Déu (HSJD), an international expert gathering at CosmoCaixa on 17 and 18 November to help identify new therapeutic strategies for rare diseases, with a special emphasis on drug repurposing already approved for other diseases. 

 

TPM Program: twenty-five years promoting quantity, quality and efficiency in organ donations over the world Blog Post

Promoting training for the experts of the field of organ, tissue and human cell transplantation and donation is the main aim of the Transplant Procurement Management, a worldwide reference in the training of health professionals of this field, which has taught around 13.000 experts from 100 countries over the world since it was created 25 years ago. This educational program is led by Dr. Martí Manyalich director of the DTI Foundation (Donation & Transplantation Institute), based at the Barcelona Science Park.

 

Gaia, the first intuitive SaaS software for human, animal & plant metagenomics that compares samples in real time Blog Post

Sequentia Biotech based at the Barcelona Science Park (PCB) recently developed Gaia, an online bioinformatics tool able to manage and analyze metagenomic data from any microbial community (bacteria, viruses and eukaryotes) generated by new sequencing technologies (Next Generation Sequencing, NGS) applied to human, animal and plant genetics and automatically integrates all levels of taxonomic classification with functional classification (from the kingdom to the subspecies) in just 12 hours. It is also the first bioinformatics tool that compares samples in real time. This SAAS-based software is available in the cloud and does not require specialized training; making it possible for any researcher who is not versed in bioinformatics to use it. 

 

“La Marató” awards funding to two IRB Barcelona projects on obesity and diabetes Blog Post

Today the “Fundació La Marató de TV3” has announced the 34 winning projects out of 117 presented for funding in the 2015 campaign devoted to obesity and diabetes in an award presentation ceremony held at the Acadèmia de Ciències Mèdiques i de la Salut de Catalunya i de Balears, in Barcelona. The Institute for Research in Biomedicine (IRB Barcelona), based at the Barcelona Science Park, has received funding for the two projects that it presented.